Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation
Status:
Unknown status
Trial end date:
2019-09-24
Target enrollment:
Participant gender:
Summary
Plasma exchange procedures remove procoagulant and anticoagulant factors. Every procedure
increases the risk of bleeding and repeated procedures increase the risk of bleeding mostly
because lower fibrinogen levels. The aim of study is to define coagulation status of patient
after plasmapheresis with different laboratory tests and to investigate the possibility of
fibrinogen concentrate replacement for the correction of induced coagulation disorder.